Malaysia is embarking on a clinical study to evaluate the drug Tocilizumab for the treatment of severe cases of Covid-19.
Led by Universiti Malaya Faculty of Medicine dean Professor Datuk Dr Adeeba Kamarulzaman, the trial is underway at Universiti Malaya Medical Centre (UMMC), together with three public hospitals: Sungai Buloh Hospital, Kuala Lumpur Hospital and Tuanku Jaafar Hospital, Seremban.
Salam Aidilfitri dari CIC! Semoga Syawal ini diberkati dengan kegembiraan dan keberkatan untuk anda dan seluruh warga keluarga. #LeaderinClinicalResearch#ClinicalInvestigationcentre#ClinicalResearchinMalaysia#ClinicalResearch
21-22 March 2024 – CIC represented by Dr Phan joined the “Expert Consultation on Strengthening Clinical Trials in the Western Pacific” organized by World Health
Wishing you wonderful Merry Christmas & a Happy New Year 2024! #BeAHero#CIC#UMMC#LeaderinClinicalResearch#ClinicalResearchinMalaysia#ClinicalInvestigationCentre#MedicalDevice#Phase1#phaseoneB
© CIC. All Rights Reserved. 2024